Pathway Financial Advisers’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-284
| Closed | -$18.6K | – | 179 |
|
|
2024
Q4 | $18.6K | Hold |
284
| – | – | 0.01% | 313 |
|
|
2024
Q3 | $22.1K | Hold |
284
| – | – | 0.01% | 244 |
|
|
2024
Q2 | $22.2K | Sell |
284
-148
| -34% | -$11.5K | 0.01% | 278 |
|
|
2024
Q1 | $29.3K | Buy |
432
+148
| +52% | +$10K | 0.01% | 270 |
|
|
2023
Q4 | $19.1K | Sell |
284
-244
| -46% | -$16.4K | 0.01% | 300 |
|
|
2023
Q3 | $35.8K | Buy |
+528
| New | +$35.8K | 0.01% | 245 |
|
|
2023
Q1 | $36.5K | Buy |
526
+3
| +0.6% | +$208 | 0.01% | 253 |
|
|
2022
Q4 | $35.5K | Buy |
+523
| New | +$35.5K | 0.01% | 272 |
|